Yahoo Web Search

Search results

1. • 

     Earnings call: ClearPoint Neuro sees robust Q1 growth with diverse revenue streams By Investing.com

     Investing.com· 6 days ago

     This growth was driven by significant gains in biologics and drug delivery, as well as capital...

2. • Some forms of augmented brain stimulation recommen | Newswise

     Newswise· 11 hours ago

     Waltham — According to a review published in Harvard Review of Psychiatry, part of the Lippincott portfolio from Wolters Kluwer, certain combinations of ...

3. • Precigen (PGEN) to Release Quarterly Earnings on Tuesday

     ETF DAILY NEWS· 4 days ago

     Precigen (NASDAQ:PGEN – Get Free Report) is scheduled to release its earnings data after the market closes on Tuesday, May 14th. Analysts expect Precigen to post earnings of ($0.09) per share ...

4. • Inogen (NASDAQ:INGN) Earns Hold Rating from Needham & Company LLC

     ETF DAILY NEWS· 4 days ago

     Needham & Company LLC reissued their hold rating on shares of Inogen (NASDAQ:INGN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports ...

5. • Brokerages Set Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Price Target at $90.17

     ETF DAILY NEWS· 4 days ago

     Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat.com reports ...

6. • Leerink Partnrs Comments on LENZ Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:LENZ)

     ETF DAILY NEWS· 3 days ago

     LENZ Therapeutics, Inc. (NASDAQ:LENZ – Free Report) – Equities research analysts at Leerink Partnrs increased their Q2 2024 EPS estimates for shares of LENZ Therapeutics in a research report ...

7. • Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $13.67 Consensus Price Target from Brokerages

     ETF DAILY NEWS· 4 days ago

     Shares of Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the seven brokerages that are currently covering the stock, MarketBeat.com ...

8. • 

     Earnings call: Bionano reports solid growth in Q1 2024, maintains guidance

     Investing.com· 6 days ago

     Bionano Genomics, Inc. (BNGO) announced its financial results for the first quarter of 2024, showing...

9. • Mizuho Trims uniQure (NASDAQ:QURE) Target Price to $6.00

     ETF DAILY NEWS· 4 days ago

     Several other equities research analysts have also weighed in on QURE. Royal Bank of Canada reissued an outperform rating and set a $28.00 price objective on shares of uniQure in a research ...

10. • 

      DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript

      Insider Monkey via Yahoo Finance· 2 days ago

      DiaMedica Therapeutics Inc. (NASDAQ:DMAC) Q1 2024 Earnings Call Transcript May 11, 2024 DiaMedica...